GlassScriptPhysician profile
Douglas P Farman
NPI 1144310954
$2,251.05
in general payments reported to CMS, 2019-2025
18 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.04 · 2022: $29.52 · 2023: $380 · 2024: $672 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,104.70 |
| Education | $101.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $479.84 | 2023-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Insmed, INC. | $353.03 | 2023-2025 | Arikayce, Brinsupri |
| Ani Pharmaceuticals, INC. | $217.56 | 2024 | Purified Cortrophin Gel |
| Philips North America LLC | $195.46 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Baxter Healthcare | $167.88 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $135.07 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2023 | Cuvitru |
| Regeneron Healthcare Solutions, INC. | $90.04 | 2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $89.99 | 2025 | |
| Genzyme Corporation | $88.10 | 2025 | |
| Amgen INC. | $73.75 | 2024-2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $57.62 | 2024-2025 | Nuzyra |
| Astrazeneca Pharmaceuticals LP | $51.81 | 2023-2025 | Breztri, Tezspire |
| Inspire Medical Systems, INC. | $43.66 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $29.52 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $20.06 | 2023 | Flexitouch Plus, Entre Plus |
| Bayer Healthcare Pharmaceuticals INC. | $17.62 | 2023 | |
| Gilead Sciences, INC. | $15.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Farman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.